Woman Recovers from Debilitating Breast Condition with Personalized Ozone Therapy
Translated from Turkish, summarized and contextualized by DistantNews.
At a glance
- A 35-year-old woman, Meltem Çetin Arıkan, recovered from granulomatous mastitis after receiving a personalized treatment plan from Breast Surgery Specialist Assoc. Prof. Dr. Pelin Basım.
- Granulomatous mastitis, a condition causing pain, swelling, and inflammation in the breast, can be mistaken for cancer and is known for its long duration and high recurrence risk.
- Arıkan experienced a difficult year with ineffective antibiotic treatments before Dr. Basım diagnosed the condition and implemented a successful ozone therapy regimen.
Meltem Çetin Arıkan, a 35-year-old woman, has regained her health after receiving accurate diagnosis and personalized treatment for granulomatous mastitis from Breast Surgery Specialist Assoc. Prof. Dr. Pelin Basım. The condition, characterized by breast pain, swelling, and inflammation, can be mistaken for cancer but is a distinct disease with a high risk of recurrence.
Granulomatosis mastitis, which progresses with pain, swelling, and inflammation in the breast, is a different disease that can be confused with cancer.
Dr. Basım explained that granulomatous mastitis is an inflammatory breast disease that, while not related to cancer, can cause significant anxiety due to symptoms like pain, swelling, and abscesses. The prolonged nature and high recurrence rate of the illness can make it a particularly taxing experience for patients. "Granulomatous mastitis is an inflammatory and infectious disease of the breast," Dr. Basım stated. "It is not related to cancer, but it can cause serious anxiety in patients because it presents with symptoms such as breast pain, swelling, and abscesses."
Arıkan had sought treatment for about a year, undergoing various antibiotic therapies that proved ineffective before consulting Dr. Basım. After thorough examinations, Dr. Basım diagnosed idiopathic granulomatous mastitis, a condition with an unknown exact cause. Initially, a short-term steroid treatment was administered to manage the widespread inflammation.
It is not related to cancer, but it can cause serious anxiety in patients because it presents with symptoms such as breast pain, swelling, and abscesses. It is a disease with a long duration and a high risk of recurrence, so it can turn into a very debilitating process for patients.
Following the initial phase of inflammation control, Dr. Basım developed a personalized ozone therapy plan for Arıkan. This treatment, described as physiological and free of side effects, involved both systemic and local ozone applications, leading to the disease's regression. After approximately 4-5 months of intensive treatment, Arıkan recovered without experiencing the side effects common with other treatment methods for this condition. "After controlling the first phase of inflammation, we planned personalized ozone therapy for our patient," Dr. Basım said. "With both systemic and local ozone applications, which are completely physiological and have no side effects, we achieved the regression of the disease."
After controlling the first phase of inflammation, we planned personalized ozone therapy for our patient. With both systemic and local ozone applications, which are completely physiological and have no side effects, we achieved the regression of the disease.
Arıkan shared her challenging journey, noting the anxiety and uncertainty associated with the illness. "The hardest part of this process was the uncertainty and anxiety," she said. "I constantly worried, 'Will it recur?' I was worn out by different treatments, drainage procedures, and medications for about 8-9 months. With ozone therapy, I recovered comfortably and without side effects."
The hardest part of this process was the uncertainty and anxiety. I constantly worried, 'Will it recur?' I was worn out by different treatments, drainage procedures, and medications for about 8-9 months. With ozone therapy, I recovered comfortably and without side effects.
Originally published by Cumhuriyet in Turkish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.